IFNG-AS1 and breast carcinoma: lncRNA interferon (IFN) gamma antisense RNA 1 (IFNG-AS1) also called TMEVPG1 or NeST, was first reported in the immune system of diseases and acted crucial oncogenic role in several types of cancers, such as pituitary adenomas [14], breast cancer [15], and acute leukemia [16].